查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390731

家禽疫苗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Poultry Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球家禽疫苗市场规模达18亿美元。展望未来， IMARC Group预计到2028年市场规模将达到26亿美元，2022-2028年复合年增长率（CAGR）为6.32%。家禽疾病预防意识的增强、对安全无病家禽产品的需求不断增加以及疫苗开发技术的不断进步以确保永续生产是推动市场成长的主要因素。

家禽疫苗是专门用于保护家禽（例如鸡、鸭和火鸡）免受传染病侵害的生物製品。它的配方可以触发鸟类的免疫反应，使它们能够对特定病原体（包括病毒和细菌）产生免疫力。疫苗接种过程可以透过不同的途径进行，例如注射、气雾剂或透过鸟类的饮用水进行。疫苗接种计划是根据一个地区流行的特定疾病风险量身定制的，是家禽养殖场生物安全措施的一个组成部分。此外，农民可以透过使用适当的家禽疫苗，有效减轻疾病爆发并确保家禽产品的可持续和安全生产。如今，家禽疫苗对于维持家禽族群的健康和福祉至关重要。

该市场主要受到生物製品需求不断增长的推动。此外，对肉类和鸡蛋等家禽产品的需求不断增加，导致家禽产量增加，从而影响了市场成长。与此相适应，不断增长的家禽数量需要使用疫苗来保护家禽并维持生产水平，从而促进市场成长。此外，家禽养殖户和生产者越来越意识到预防性医疗措施（包括疫苗接种）的重要性，以确保其鸡群的福祉和生产力，这是另一个主要的成长诱导因素。除此之外，疫苗接种被认为是控制和预防传染病传播的一种经济有效的方法，减少对抗生素和其他治疗的需求，从而推动市场成长。除此之外，强调食品安全和动物福利重要性的多项政府政策的实施正在加速市场成长。此外，疫苗技术和研究的进步导致了更有效和更有针对性的疫苗的开发，提高了其功效和安全性，从而创造了积极的市场前景。

家禽疫苗市场趋势/驱动因素：

家禽消费不断增加

对鸡肉、肉类和鸡蛋等家禽产品的需求不断增长正在影响市场的成长。此外，人口的成长、都市化的快速发展、人们忙碌的生活方式正在不断增加对家禽产品的需求，从而促进了市场的成长。此外，家禽养殖户正在将疫苗接种作为预防措施，以保护其鸡群并确保稳定供应安全无病的产品，这是另一个主要的生长诱导因素。除此之外，疫苗提供了一种有效且高效的方法来保护家禽免受传染病的侵害，减少疫情爆发和相关生产损失的可能性，从而加速市场成长。除此之外，农民还可以提高家禽健康和生产力，透过免疫鸡群来提高家禽业的效率和获利能力，从而推动市场成长。除此之外，家禽消费的成长导致家禽和家禽产品的国际贸易增加，进而推动市场成长。

疾病预防意识不断增强

家禽中传染病发病率的不断上升导致农民和生产者广泛采用疫苗来实施预防措施来保护其鸡群，从而影响市场成长。此外，农民越来越多地投资于疫苗接种计划，以保障其投资、控制疾病并帮助减少家禽传染病的发生率和严重程度，这是另一个主要的成长诱导因素。除此之外，农民还可以防止疾病传播并最大程度地减少生产损失，透过对鸡群进行免疫确保持续供应健康的家禽产品，以满足消费者的需求，从而加速市场成长。同时，人们对健康意识的增强和对安全优质食品的需求不断增加，有助于在疫苗的帮助下生产安全卫生的家禽产品，从而推动市场成长。此外，消费者对疫苗接种家禽益处的认识不断增强，进一步推动了对家禽疫苗的需求，鼓励生产商将疫苗接种作为其疾病预防策略的一个重要方面。

疫苗开发的新兴技术进步

现代疫苗的开发可以生产出效力更高、免疫力更持久的疫苗，为多种家禽疾病提供更好的保护，进而促进市场成长。此外，生物技术、创新方法和技术的不断发展正在催生更有效、更安全和更有针对性的家禽疫苗，这是另一个主要的生长诱导因素。除此之外，佐剂和载体疫苗、家禽疫苗等疫苗传递系统的广泛进步现在可以引发更强大和特异性的免疫反应，从而加速市场成长。同时，这些突破导致了客製化疫苗的开发，可以满足各种家禽品种的特定需求和区域疾病挑战，从而推动市场成长。此外，疫苗配方的进步导致生产出更稳定和耐温的疫苗，延长了其保质期并减少了冷链储存和运输的需求，从而使家禽养殖户更容易分发和获得疫苗，特别是在偏远或资源丰富的地区-受限地区，从而创造积极的市场前景。

家禽疫苗行业细分：

IMARC Group提供了全球家禽疫苗市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据疾病、产品、剂型、应用和最终用户对市场进行了分类。

因疾病而分手：

传染性支气管炎

禽流感

新城疫

马立克氏症

其他的

新城疫是最常见的疾病

该报告根据疾病提供了详细的市场细分和分析。这包括传染性支气管炎、禽流感、新城疫、马立克氏症等。报告称，新城疫占据了最大的市场份额。

新城疫（ND）是一种高度传染性的病毒性疾病，影响多种禽类，包括鸡、火鸡和鸽子，对家禽业带来严重的经济损失。此外，新城疫因其快速传播和对家禽群的破坏性影响而成为家禽养殖户和生产者的主要担忧，从而影响市场成长。此外，新城疫的爆发可能导致高死亡率、产蛋量减少和饲料转换效率降低，对家禽业带来巨大的经济损失，进而促进市场成长。除此之外，疫苗接种对于家禽生产者的预防措施至关重要，有助于增强对病毒的免疫力，降低感染的严重程度，并最大限度地减少疾病在鸡群中的传播，从而推动市场增长。除此之外，定期、及时地对家禽进行疫苗接种对于预防新城疫爆发和保持鸡群健康至关重要，从而加速市场成长。除此之外，家禽养殖户依靠这些疫苗来确保鸡群的健康，确保投资，并维持无病家禽产品的稳定供应，以满足消费者的需求，从而为市场成长提供积极的推动力。

按产品划分：

重组疫苗

减毒活疫苗

灭活疫苗

亚单位疫苗

其他的

减毒活疫苗是最受欢迎的产品

该报告根据产品提供了详细的市场细分和分析。这包括重组疫苗、减毒活疫苗、不活化疫苗、次单位疫苗等。报告称，减毒活疫苗占据最大的市场份额。

减毒活疫苗是由弱化形式的病原体开发而成，保留了在宿主体内诱导免疫反应的能力，而不引起严重疾病，有助于市场成长。此外，减毒活疫苗在提供针对多种家禽疾病的持久免疫力方面具有卓越功效，进而影响市场成长。这些疫苗引发体液和细胞介导的免疫反应，为家禽群提供强而有力的保护。此外，减毒活疫苗模仿自然感染，产生全面、持续的免疫防御，可以治疗多种家禽疾病，包括禽流感、新城疫和传染性支气管炎，这是另一个主要的生长诱导因素。除此之外，减毒活疫苗针对不同病原体菌株提供交叉保护的能力增加了它们对家禽养殖户和生产者的吸引力，加速了市场成长。除了功效之外，减毒活疫苗通常具有成本效益，使其成为大规模家禽生产的有吸引力的选择，从而推动市场成长。

按剂型划分：

液体疫苗

冻干疫苗

液体疫苗目前占据最大的市场份额

该报告根据剂型对市场进行了详细的细分和分析。这包括液体疫苗和冷冻干燥疫苗。报告称，液体疫苗占据最大的市场份额。

液体疫苗以其易于给药而闻名，可以透过饮用水或皮下或肌肉注射来输送，使疫苗接种过程更加简单和高效。此外，在对大型鸡群进行疫苗接种时，管理的简单性尤其重要，因为它可以最大限度地减少疫苗接种程序所需的时间和精力，从而促进市场成长。此外，液体疫苗在剂量方面具有更好的均匀性和一致性，它们在疫苗溶液中充分混合，确保每隻鸡接受准确且均匀剂量的疫苗，这是另一个主要的生长诱导因素。这种一致性对于在整个家禽群中实现最佳免疫水平和最大限度地提高疫苗效力至关重要。

除此之外，液体疫苗比其他剂型更具成本效益，因为它的製造成本较低，而且其有效的管理减少了对专用设备或额外劳动力的需求，进一步加速了市场成长。此外，液体疫苗的便利性和可靠性有助于其在家禽业的广泛采用，因为家禽养殖户正在寻求实用的解决方案来保护其羊群免受疾病侵害，从而创造积极的市场前景。

按应用划分：

饲养员

肉鸡

层

肉鸡市场领先地位

报告还提供了基于应用程式的详细市场细分和分析。这包括种鸡、肉鸡和蛋鸡。报告称，肉鸡占最大的市场份额。

肉鸡是专门为肉类生产而饲养的鸡，加速了市场的成长。此外，由于肉鸡肉的价格实惠、多功能性和营养价值，对肉鸡的需求不断增加，也促进了市场的成长。随着全球人口持续成长，对高效和永续蛋白质来源的需求越来越大，这使得肉鸡肉成为消费者和食品产业有吸引力的选择。此外，肉鸡养殖的密集性质和大规模商业化生产需要高度重视疾病预防和生物安全，这是另一个主要的生长诱导因素。除此之外，由于饲养密度高，在密闭空间饲养的肉鸡更容易感染传染病，因此疫苗接种成为其健康管理的重要方面，从而推动了市场的成长。除此之外，与其他家禽品种（例如蛋鸡（产蛋母鸡））相比，肉鸡的生产週期更短。这意味着在更短的时间内生产和加工更多数量的肉鸡，导致对家禽疫苗的需求不断增加，以保护这些家禽免受可能影响生产和盈利能力的潜在疾病爆发，从而创造积极的市场前景。

按最终用户划分：

兽医院

家禽公司

家禽疫苗接种中心

报告还提供了基于最终用户的详细市场细分和分析。这包括兽医医院、家禽公司和家禽疫苗接种中心。

兽医院对于家禽疫苗的分发和管理至关重要。它们对于向家禽养殖户和生产者提供医疗服务和建议至关重要。此外，他们还提供诊断疾病、开出合适疫苗以及对家禽进行疫苗接种等方面的专业知识，从而促进市场成长。这些机构是值得信赖的资讯来源，对于促进家禽养殖户采用疫苗接种做法至关重要。

此外，家禽公司，包括商业家禽养殖场和综合家禽公司，是家禽疫苗的重要消费者。这些公司管理着大规模的家禽经营，并在确保鸡群的健康和生产力方面投入了大量资金。除此之外，疫苗接种是其疾病预防和生物安全策略的一个组成部分，因为它有助于保护整个家禽族群免受传染病的侵害，从而为市场成长提供积极的推动力。家禽公司批量采购疫苗是为了对其庞大的鸡群进行免疫，并最大限度地降低疾病爆发的风险，疾病爆发可能导致大量生产损失，从而影响市场成长。

除此之外，家禽疫苗接种中心是专门为家禽注射疫苗的专门设施。这些中心可能由私人实体或政府机构营运。它们满足了小规模家禽养殖户和放养家禽饲养者的需求，他们可能无法进入兽医院或缺乏疫苗接种程序的专业知识，从而加速市场成长。家禽疫苗接种中心提供方便的疫苗接种、疫苗接种服务并协助实施适当的疫苗接种计划，以确保家禽的健康和福祉。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美在市场上表现出明显的主导地位

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

北美的发展得益于先进的家禽养殖方法、强有力的生物安全措施以及家禽养殖户对疾病预防的高度认识，从而影响了市场的成长。此外，美国和加拿大是家禽疫苗需求不断增长的主要推动者，因为这些国家拥有完善的家禽业，注重现代生产技术和严格的生物安全标准，加速了市场成长。此外，广泛采用先进的疫苗接种计划对于保护家禽群免受传染病、确保持续可靠的家禽产品供应以满足消费者需求至关重要，这是另一个主要的成长诱导因素。

此外，在欧洲市场，英国、德国、法国、荷兰等国家家禽业发达，优先透过疫苗接种预防疾病，进而促进了市场成长。同时，在亚太市场，中国、印度和巴西等国家的家禽生产和消费正大幅成长。随着这些地区家禽养殖活动的增加，对家禽疫苗的需求不断增长，以降低疾病风险并确保家禽群的健康和生产力，从而创造了积极的市场前景。

竞争格局：

如今，市场上的主要参与者正在实施各种策略，以巩固自己的地位并获得行业竞争优势。他们正在投资研发 (R&D)，以开发先进、更有效的家禽疫苗，并探索新技术和创新方法，以提高疫苗的功效、安全性和免疫力持续时间。此外，公司正在与研究机构、大学和家禽协会等其他行业利益相关者建立策略合作和伙伴关係，使公司能够站在疫苗开发的最前沿并在竞争中保持领先地位。除此之外，主要参与者正在迎合更广泛的家禽疾病和物种，并透过推出针对特定病原体的新疫苗和采用更个人化的方法来应对区域疾病挑战来扩大其产品组合。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

AniCon Labor GmbH（SAN 集团）Biovac Ltd.

勃林格殷格翰国际股份有限公司

塞瓦圣动物

埃兰科

海丝特生物科学有限公司

默克公司

菲布罗动物保健公司

印度文克斯

硕腾公司

最近的发展：

2020年1月，勃林格殷格翰国际有限公司推出了VAXXITEK HVT+IBD+ND疫苗，用于保护家禽免受新城疫、马立克氏病和传染性法氏囊病（经典型和变异型）的侵害。他们在其工厂生产 VAXXITEK HVT+IBD+ND，该工厂每年开发超过 600 亿剂家禽疫苗，供美国和其他 60 多个国家使用。

2022 年10 月，硕腾公司推出了Poulvac Procerta HVT-IBD-ND，这是一种重组载体疫苗，只需一剂即可针对传染性法氏囊、马立克氏病和新城疫病毒提供早期/强有力的保护，同时扩大其家禽疫苗产品组合。

2022 年 4 月，Elanco 与 Ginkgo Bioworks 合作，推出了一家名为 BiomEdit 的新动物保健公司，为牲畜开发营养产品、药物和疾病监测方法，旨在解决抗生素抗药性并提高永续性。

本报告回答的关键问题

  • 2022年全球家禽疫苗市场规模是多少
  • 2023-2028年全球家禽疫苗市场的预期成长率是多少
  • COVID-19 对全球家禽疫苗市场有何影响
  • 推动全球家禽疫苗市场的关键因素是什么
  • 根据该疾病，全球家禽疫苗市场的细分如何
  • 根据产品，全球家禽疫苗市场的细分如何
  • 根据剂型，全球家禽疫苗市场的细分如何
  • 根据应用，全球家禽疫苗市场的细分如何
  • 全球家禽疫苗市场的重点区域有哪些
  • 10. 全球家禽疫苗市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2022年全球家禽疫苗市场规模有多大？
  • 2023-2028年全球家禽疫苗市场的预期成长率是多少？
  • COVID-19 对全球家禽疫苗市场有何影响？
  • 推动全球家禽疫苗市场的关键因素是什么？
  • 全球家禽疫苗市场因该疾病而出现怎样的分化？
  • 根据产品，全球家禽疫苗市场的细分如何？
  • 根据剂型，全球家禽疫苗市场的细分如何？
  • 根据应用，全球家禽疫苗市场的细分如何？
  • 全球家禽疫苗市场的重点区域有哪些？
  • 全球家禽疫苗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球家禽疫苗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：疾病导致的市场区隔

  • 传染性支气管炎
    • 市场走向
    • 市场预测
  • 禽流感
    • 市场走向
    • 市场预测
  • 新城疫
    • 市场走向
    • 市场预测
  • 马立克氏症
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按产品分類的市场区隔

  • 重组疫苗
    • 市场走向
    • 市场预测
  • 减毒活疫苗
    • 市场走向
    • 市场预测
  • 灭活疫苗
    • 市场走向
    • 市场预测
  • 亚单位疫苗
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按剂型分類的市场区隔

  • 液体疫苗
    • 市场走向
    • 市场预测
  • 冻干疫苗
    • 市场走向
    • 市场预测

第 9 章：按应用分類的市场区隔

  • 饲养员
    • 市场走向
    • 市场预测
  • 肉鸡
    • 市场走向
    • 市场预测
  • 层
    • 市场走向
    • 市场预测

第 10 章：最终用户的市场区隔

  • 兽医院
    • 市场走向
    • 市场预测
  • 家禽公司
    • 市场走向
    • 市场预测
  • 家禽疫苗接种中心
    • 市场走向
    • 市场预测

第 11 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AniCon Labor GmbH (SAN Group)
    • Biovac Ltd.
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco
    • Hester Biosciences Limited
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Venkys India
    • Zoetis Inc.
Product Code: SR112023A4547

Abstract

The global poultry vaccines market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.32% during 2022-2028. The growing awareness of disease prevention among poultry, the increasing demand for safe and disease-free poultry products, and the continuous technological advancements in vaccine development to ensure sustainable production are major factors driving the market growth.

Poultry vaccines are biological products specifically designed to protect domestic birds, such as chickens, ducks, and turkeys, from infectious diseases. It is formulated to trigger an immune response in birds, enabling them to develop immunity against specific pathogens, including viruses and bacteria. The vaccination process can be administered through different routes, such as injection, aerosol, or in the drinking water of the birds. Vaccination programs are customized to the specific disease risks prevalent in a region, and they are an integral part of biosecurity measures on poultry farms. Additionally, farmers can effectively mitigate disease outbreaks and ensure the sustainable and safe production of poultry products, by utilizing appropriate poultry vaccines. Nowadays, poultry vaccines are essential in maintaining the health and welfare of poultry populations.

The market is primarily driven by the rising demand for biological products. In addition, the escalating demand for poultry products, including meat and eggs led to increased poultry production, thus influencing the market growth. In line with this, the growing poultry populations are necessitating the use of vaccines to protect the birds and maintain production levels, thus contributing to market growth. Moreover, the growing awareness among poultry farmers and producers about the importance of preventive healthcare measures, including vaccination, to ensure the well-being and productivity of their flocks represents another major growth-inducing factor. Along with this, vaccination is considered a cost-effective and efficient method to control and prevent the spread of infectious diseases, reducing the need for antibiotics and other treatments, thus propelling market growth. Besides this, the implementation of several government policies emphasizing the importance of food safety and animal welfare are accelerating the market growth. Furthermore, advancements in vaccine technology and research led to the development of more effective and targeted vaccines, improving their efficacy and safety profiles, thus creating a positive market outlook.

Poultry Vaccines Market Trends/Drivers:

The increasing poultry consumption

The rising demand for poultry products, such as chicken, meat, and eggs is influencing the market growth. In addition, the growing population, rapid urbanization, busy lifestyles of individuals are escalating the demand for poultry products, thus contributing to the market growth. Moreover, poultry farmers are turning to vaccination as a preventive measure to protect their flocks and ensure a steady supply of safe and disease-free products representing another major growth-inducing factor. Besides this, vaccines offer an effective and efficient way to protect poultry from infectious diseases, reducing the likelihood of outbreaks and associated production losses, thus accelerating market growth. Along with this, farmers can enhance bird health and productivity, leading to improved efficiency and profitability in the poultry industry by immunizing their flocks, thus propelling market growth. Apart from this, the rising poultry consumption has led to increased international trade of poultry and poultry products, thus propelling market growth.

The growing awareness regarding disease prevention

The growing incidences of infectious diseases in poultry populations are resulting in the widespread adoption of vaccines by farmers and producers to implement preventive measures to protect their flocks, thus influencing market growth. Moreover, farmers are increasingly investing in vaccination programs to safeguard their investments, control disease, and help reduce the incidence and severity of infectious diseases in poultry representing another major growth-inducing factor. Besides this, farmers can prevent disease spread and minimize production losses, ensuring a consistent supply of healthy poultry products to meet consumer demands by immunizing their flocks, thus accelerating market growth. Along with this, the increasing health-conscious and escalating demand for safe and high-quality food products is contributing to the production of safe and wholesome poultry products with the help of vaccines, thus propelling market growth. Furthermore, the growing awareness among consumers about the benefits of vaccinated poultry further drives the demand for poultry vaccines, encouraging producers to prioritize vaccination as a critical aspect of their disease prevention strategies.

The emerging technological advancements in vaccine development

The development of modern vaccines allows the production of vaccines with improved efficacy and longer-lasting immunity, providing better protection against numerous poultry diseases, thus contributing to market growth. Moreover, the continuous development in biotechnology, innovative approaches, and techniques are leading to the creation of more effective, safe, and targeted poultry vaccines representing another major growth-inducing factor. Besides this, the extensive advancements in vaccine delivery systems, such as adjuvants and vector-based vaccines, poultry vaccines can now trigger a more robust and specific immune response thus accelerating the market growth. Along with this, these breakthroughs led to the development of customized vaccines that can address the specific needs of various poultry species and regional disease challenges, thus propelling market growth. Furthermore, advancements in vaccine formulation led to the creation of more stable and temperature-tolerant vaccines, enhancing their shelf life and reducing the need for cold chain storage and transportation leading to easier distribution and accessibility of vaccines to poultry farmers, especially in remote or resource-constrained regions, thus creating a positive market outlook.

Poultry Vaccines Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global poultry vaccines market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on disease, product, dosage form, application and end user.

Breakup by Disease:

Infectious Bronchitis

Avian Influenza

Newcastle Disease

Marek's Disease

Others

Newcastle disease represents the most common disease

The report has provided a detailed breakup and analysis of the market based on the disease. This includes infectious bronchitis, avian influenza, newcastle disease, marek's disease, and others. According to the report, Newcastle disease accounted for the largest market share.

Newcastle disease (ND) is a highly contagious viral disease that affects various avian species, including chickens, turkeys, and pigeons, leading to severe economic losses in the poultry industry. In addition, newcastle disease is a primary concern for poultry farmers and producers due to rapid transmission and devastating impact on poultry flocks, thus influencing the market growth. Also, outbreaks of ND can result in high mortality rates, reduced egg production, and decreased feed conversion efficiency, leading to substantial financial losses for the poultry industry, thus augmenting market growth. Along with this, vaccination is essential for preventive measures for poultry producers, to help build immunity against the virus, reduce the severity of infections, and minimize the spread of the disease among flocks, thus propelling the market growth. Besides this, the regular and timely vaccination of poultry populations is essential to protect against ND outbreaks and maintain flock health, thus accelerating market growth. Apart from this, poultry farmers are relying on these vaccines to ensure the well-being of their flocks, secure their investments, and maintain a steady supply of disease-free poultry products to meet consumer demands, thus providing a positive thrust to the market growth.

Breakup by Product:

Recombinant Vaccine

Live Attenuated Vaccine

Inactivated Vaccine

Subunit Vaccine

Others

Live attenuated vaccine represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes recombinant vaccine, live attenuated vaccine, inactivated vaccine, subunit vaccine, and others. According to the report, live attenuated vaccines accounted for the largest market share.

Live attenuated vaccines are developed from weakened forms of pathogens that retain their ability to induce an immune response in the host without causing severe disease, thus contributing to market growth. Additionally, live attenuated vaccines have superior efficacy in providing long-lasting immunity against numerous poultry diseases, thus influencing market growth. These vaccines elicit humoral and cell-mediated immune responses, offering robust protection to poultry flocks. Moreover, live attenuated vaccines mimic natural infections, leading to a comprehensive and sustained immune defense, and can address several poultry diseases, including avian influenza, Newcastle disease, and infectious bronchitis representing another major growth-inducing factor. Besides this, live attenuated vaccines' ability to confer cross-protection against different strains of pathogens adds to their appeal among poultry farmers and producers, thus accelerating the market growth. Apart from their efficacy, live attenuated vaccines are generally cost-effective, making them an attractive choice for large-scale poultry production, thus propelling the market growth.

Breakup by Dosage Form:

Liquid Vaccine

Freeze Dried Vaccine

Liquid vaccine presently accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the dosage form. This includes liquid vaccines and freeze-dried vaccines. According to the report, liquid vaccine accounted for the largest market share.

Liquid vaccines are known for their ease of administration and can be delivered through drinking water or by subcutaneous or intramuscular injection, making the vaccination process more straightforward and efficient. In addition, the ease of administration is particularly essential when vaccinating large flocks, as it minimizes the time and effort required for vaccination procedures, thus augmenting the market growth. Moreover, liquid vaccines offer better homogeneity and consistency in dosing, which are well-mixed in the vaccine solution, ensuring that each bird receives an accurate and uniform dose of the vaccine representing another major growth-inducing factor. This consistency is essential for achieving optimal immunization levels across the entire poultry population and maximizing the vaccine's efficacy.

Besides this, liquid vaccines can be more cost-effective than other dosage forms, as it involves lower manufacturing costs, and their efficient administration reduces the need for specialized equipment or additional labor, further accelerating the market growth. Furthermore, the convenience and reliability of liquid vaccines are contributing to their widespread adoption in the poultry industry as poultry farmers seek practical solutions to protect their flocks from diseases thus creating a positive market outlook.

Breakup by Application:

Breeder

Broiler

Layer

Broiler holds the leading position in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes breeder, broiler, and layer. According to the report, broilers accounted for the largest market share.

Broilers are chickens that are specifically raised for meat production thus accelerating the market growth. In addition, the escalating demand for broiler meat due to its affordability, versatility, and nutritional value is contributing to the market growth. As the global population continues to grow, there is a higher need for efficient and sustainable protein sources, making broiler meat an attractive option for consumers and food industries. Moreover, the intensive nature of broiler farming, with large-scale commercial production, necessitates a strong focus on disease prevention and biosecurity representing another major growth-inducing factor. Along with this, broilers raised in confined spaces are more susceptible to infectious diseases due to high stocking densities, making vaccination an essential aspect of their health management is propelling the market growth. Besides this, broilers have a shorter production cycle compared to other poultry species, such as layers (egg-laying hens). This means that a larger number of broilers are produced and processed within a shorter timeframe, leading to an escalating demand for poultry vaccines to protect these birds from potential disease outbreaks that could impact production and profitability, thus creating a positive market outlook.

Breakup by End User:

Veterinary Hospitals

Poultry Firm

Poultry Vaccination Center

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes veterinary hospitals, poultry firm, and poultry vaccination center.

Veterinary hospitals are essential in the distribution and administration of poultry vaccines. They are essential in providing medical care and advice to poultry farmers and producers. In addition, they offer expertise in diagnosing diseases, prescribing suitable vaccines, and administering vaccinations to poultry flocks, thus contributing to the market growth. These establishments act as trusted sources of information and are pivotal in promoting the adoption of vaccination practices among poultry farmers.

Moreover, poultry firms, including commercial poultry farms and integrated poultry companies, are significant consumers of poultry vaccines. These firms manage large-scale poultry operations and are highly invested in ensuring the health and productivity of their flocks. Along with this, vaccination is an integral part of their disease prevention and biosecurity strategies, as it helps protect the entire poultry population from infectious diseases, thus providing a positive thrust to the market growth. Poultry firms procure vaccines in bulk to immunize their vast flocks and minimize the risk of disease outbreaks that could lead to substantial production losses, thus influencing the market growth.

Besides this, poultry vaccination centers are specialized facilities dedicated to administering vaccines to poultry. These centers may be operated by private entities or government agencies. They cater to the needs of small-scale poultry farmers and backyard poultry keepers who may not have access to veterinary hospitals or lack expertise in vaccination procedures, thus accelerating the market growth. Poultry vaccination centers provide convenient access to vaccines, offer vaccination services, and assist in implementing proper vaccination schedules to ensure the health and well-being of the birds.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is driven by the presence of advanced poultry farming practices, robust biosecurity measures, and a high level of awareness about disease prevention among poultry farmers, thus influencing market growth. In addition, the United States and Canada are the major contributors to the escalating demand for poultry vaccines, as these countries boast well-established poultry industries with a focus on modern production techniques and stringent biosecurity standards, thus accelerating market growth. Moreover, the widespread adoption of advanced vaccination programs is essential in protecting poultry flocks from infectious diseases, ensuring a continuous and reliable supply of poultry products to meet consumer demands, representing another major growth-inducing factor.

Besides this, in Europe market, countries such as the United Kingdom, Germany, France, and the Netherlands have well-developed poultry industries that prioritize disease prevention through vaccination, thus augmenting market growth. Along with this, in the Asia Pacific market, countries such as China, India, and Brazil are witnessing substantial growth in poultry production and consumption. As these regions experience an increase in poultry farming activities, there is a growing demand for poultry vaccines to mitigate disease risks and ensure the health and productivity of poultry flocks, thus creating a positive market outlook.

Competitive Landscape:

Nowadays, key players in the market are implementing various strategies to strengthen their position and gain a competitive edge in the industry. They are investing in research and development (R&D) to develop advanced and more effective poultry vaccines and exploring new technologies and innovative approaches to enhance vaccine efficacy, safety, and duration of immunity. Moreover, companies are forming strategic collaborations and partnerships with other industry stakeholders, such as research institutions, universities, and poultry associations, allowing companies to stay at the forefront of vaccine development and stay ahead of the competition. Besides this, key players are catering to a broader range of poultry diseases and species and expanding their product portfolios by introducing new vaccines targeting specific pathogens and adopting a more personalized approach to address regional disease challenges.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AniCon Labor GmbH (SAN Group) Biovac Ltd.

Boehringer Ingelheim International GmbH

Ceva Sante Animale

Elanco

Hester Biosciences Limited

Merck & Co. Inc.

Phibro Animal Health Corporation

Venkys India

Zoetis Inc.

Recent Developments:

In January 2020, Boehringer Ingelheim International GmbH introduced the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Newcastle disease, Marek's disease, and infectious bursal disease (classic and variant types). They produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

In October 2022, Zoetis Inc. launched Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that offers early/robust protection against infectious bursal, Marek's, and Newcastle disease viruses with one dose, while expanding its poultry vaccine portfolio.

In April 2022, Elanco, in collaboration with Ginkgo Bioworks, introduced a new animal healthcare company called BiomEdit to develop nutritional products, drugs, and disease-monitoring methods for livestock which aim to address antibiotic resistance and improve sustainability.

Key Questions Answered in This Report

  • 1. What was the size of the global poultry vaccines market in 2022?
  • 2. What is the expected growth rate of the global poultry vaccines market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global poultry vaccines market?
  • 4. What are the key factors driving the global poultry vaccines market?
  • 5. What is the breakup of the global poultry vaccines market based on the disease?
  • 6. What is the breakup of the global poultry vaccines market based on the product?
  • 7. What is the breakup of the global poultry vaccines market based on the dosage form?
  • 8. What is the breakup of the global poultry vaccines market based on the application?
  • 9. What are the key regions in the global poultry vaccines market?
  • 10. Who are the key players/companies in the global poultry vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Poultry Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease

  • 6.1 Infectious Bronchitis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Avian Influenza
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Newcastle Disease
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Marek's Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Recombinant Vaccine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated Vaccine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated Vaccine
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit Vaccine
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Liquid Vaccine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Freeze Dried Vaccine
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Breeder
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Broiler
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Layer
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Veterinary Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Poultry Firm
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Poultry Vaccination Center
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AniCon Labor GmbH (SAN Group)
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Biovac Ltd.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Boehringer Ingelheim International GmbH
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Ceva Sante Animale
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Elanco
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Hester Biosciences Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Merck & Co. Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Phibro Animal Health Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Venkys India
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Zoetis Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Poultry Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Poultry Vaccines Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Poultry Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Poultry Vaccines Market: Breakup by Disease (in %), 2022
  • Figure 5: Global: Poultry Vaccines Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Poultry Vaccines Market: Breakup by Dosage Form (in %), 2022
  • Figure 7: Global: Poultry Vaccines Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Poultry Vaccines Market: Breakup by End User (in %), 2022
  • Figure 9: Global: Poultry Vaccines Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Poultry Vaccines (Infectious Bronchitis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Poultry Vaccines (Infectious Bronchitis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Poultry Vaccines (Avian Influenza) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Poultry Vaccines (Avian Influenza) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Poultry Vaccines (Newcastle Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Poultry Vaccines (Newcastle Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Poultry Vaccines (Marek's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Poultry Vaccines (Marek's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Poultry Vaccines (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Poultry Vaccines (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Poultry Vaccines (Recombinant Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Poultry Vaccines (Recombinant Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Poultry Vaccines (Live Attenuated Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Poultry Vaccines (Live Attenuated Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Poultry Vaccines (Inactivated Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Poultry Vaccines (Inactivated Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Poultry Vaccines (Subunit Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Poultry Vaccines (Subunit Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Poultry Vaccines (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Poultry Vaccines (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Poultry Vaccines (Liquid Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Poultry Vaccines (Liquid Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Poultry Vaccines (Freeze Dried Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Poultry Vaccines (Freeze Dried Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Poultry Vaccines (Breeder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Poultry Vaccines (Breeder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Poultry Vaccines (Broiler) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Poultry Vaccines (Broiler) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Poultry Vaccines (Layer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Poultry Vaccines (Layer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Poultry Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Poultry Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Poultry Vaccines (Poultry Firm) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Poultry Vaccines (Poultry Firm) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Poultry Vaccines (Poultry Vaccination Center) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Poultry Vaccines (Poultry Vaccination Center) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: North America: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: North America: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: United States: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: United States: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Canada: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Canada: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Asia-Pacific: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Asia-Pacific: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: China: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: China: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Japan: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Japan: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: India: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: India: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: South Korea: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: South Korea: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Australia: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Australia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Indonesia: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Indonesia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Europe: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Europe: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Germany: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Germany: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: France: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: France: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: United Kingdom: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: United Kingdom: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Italy: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Italy: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Spain: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Spain: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Russia: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Russia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Latin America: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Latin America: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Brazil: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Brazil: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Mexico: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Mexico: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Middle East and Africa: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Middle East and Africa: Poultry Vaccines Market: Breakup by Country (in %), 2022
  • Figure 94: Middle East and Africa: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Global: Poultry Vaccines Industry: SWOT Analysis
  • Figure 96: Global: Poultry Vaccines Industry: Value Chain Analysis
  • Figure 97: Global: Poultry Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Poultry Vaccines Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Poultry Vaccines Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 3: Global: Poultry Vaccines Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Poultry Vaccines Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
  • Table 5: Global: Poultry Vaccines Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Poultry Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Poultry Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Poultry Vaccines Market: Competitive Structure
  • Table 9: Global: Poultry Vaccines Market: Key Players